Bilcare Ltd-$
Bilcare Ltd-$ (BI) last traded at ₹93.4, a market capitalisation of ₹220 crore, on a P/E of 11.1. Over the past 52 weeks the stock has ranged between ₹50 and ₹116. Bilcare Ltd-$ last reported results for the quarter ended Jun 2026, with sales of ₹226 crore and net profit of ₹15 crore. Figures are as of 25 Aug 2026 and are not real time.
Bilcare Ltd-$ share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Bilcare Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹226 cr, up 21.5% from ₹186 cr a year earlier. Net profit turned positive at ₹15 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 198 | 194 | 186 | 178 | 181 | 188 | 226 |
| Expenses | 194 | 187 | 186 | 175 | 175 | 168 | 171 | 189 |
| Operating profit | 8 | 11 | 8 | 11 | 3 | 13 | 17 | 37 |
| OPM % | 3.8% | 5% | 4.0% | 6% | 1.9% | 7% | 9% | 16% |
| Other income | -6 | -6 | 21 | 6 | 4 | 3 | 12 | 0 |
| Interest | 24 | 19 | 19 | 19 | 19 | 17 | 18 | 18 |
| Depreciation | 11 | 12 | 5 | 12 | 12 | 5 | 5 | 4 |
| Profit before tax | -33 | -27 | 6 | -13 | -24 | -6 | 7 | 15 |
| Tax % | -10% | -40% | -119% | -25% | -1% | 3% | -13% | -1% |
| Net profit | -30 | -16 | 12 | -10 | -23 | -6 | 8 | 15 |
| EPS (₹) | -6.81 | -3.04 | 7.47 | -1.61 | -5.25 | 0.41 | 5.68 | 5.39 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Bilcare Ltd-$ annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 623 | 845 | 982 | 747 | 788 | 734 | 773 |
| Operating profit | 51 | 60 | 57 | 39 | 45 | 44 | 70 |
| OPM % | 8% | 7% | 6% | 5% | 6% | 6% | 9% |
| Net profit | -11 | -4 | 50 | -59 | -56 | -17 | -6 |
| EPS (₹) | -8.95 | -5.35 | 6.39 | -14.12 | -12.23 | 0.73 | 6.23 |
TTM is the trailing twelve months to the most recent quarter.
Bilcare Ltd-$ growth and returns
- 10 Years
- -12%
- 5 Years
- 3%
- 3 Years
- -9%
- TTM
- -1%
- 10 Years
- -9%
- 5 Years
- 16%
- 3 Years
- 37%
- TTM
- 248%
- 10 Years
- 7%
- 5 Years
- 6%
- 3 Years
- 6%
- 1 Year
- 43%
- 10 Years
- -46%
- 5 Years
- -6%
- 3 Years
- -4%
- Last Year
- 2%
Bilcare Ltd-$ shareholding pattern
Promoters held 30.01% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.04%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% |
| FIIs | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| Public | 69.95% | 69.95% | 69.95% | 69.95% | 69.94% | 69.95% | 69.95% | 69.94% |
| No. of shareholders | 18,241 | 18,496 | 17,586 | 17,047 | 16,513 | 16,068 | 15,824 | 15,777 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Cruxal coverage of Bilcare Ltd-$
Bilcare Ltd-$ corporate filings
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Guttikonda Rajasekhar & OthersInsider Trading / SASTlow impact
Cruxal's analysis: Bilcare Limited has reported a change in shareholding under SEBI (SAST) Regulations…
Read the full analysis - Bilcare Limited has informed the Exchange about the Newspaper Publication of Quarterly Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June 2026.Company Updatehigh impact
Cruxal's analysis: Bilcare Limited has reported a significant financial turnaround for the quarter ended 30…
Read the full analysis - Bilcare Limited has informed the Exchange about the Voluntary winding up of wholly owned subsidiary.Company Updatelow impact
Cruxal's analysis: Bilcare Limited has formally notified the exchange regarding the voluntary winding up of…
Read the full analysis - Bilcare Limitedhas informed the Exchange about the outcome of Board Meeting.Board Meetingmedium impact
Cruxal's analysis: Bilcare Limited reported standalone revenue from operations of 1.94 crore for the quarter…
Read the full analysis - Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone ....Board Meetinglow impact
Cruxal's analysis: Bilcare Limited has formally intimated the Bombay Stock Exchange regarding a Board of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Bilcare Ltd-$
Cruxal reads every Bilcare Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.